Literature DB >> 33548734

Sorted B cell transcriptomes point towards actively regulated B cell responses during ongoing chronic hepatitis B infections.

Stijn Van Hees1, Bart Cuypers2, Stefan Bourgeois3, Zwier M A Groothuismink4, Pieter Meysman5, Pieter Van der Vlies6, Rob de Knegt4, Luisa Vonghia1, Peter Michielsen1, Sven Francque1, Kris Laukens5, Andre Boonstra4, Thomas Vanwolleghem7.   

Abstract

The natural course of chronic hepatitis B virus (HBV) infections follows distinct clinical disease phases, characterized by fluctuating levels of serum HBV DNA and ALT. The immune cells and their features that govern these clinical disease transitions remain unknown. In the current study, we performed RNA sequencing on purified B cells from blood (n = 42) and liver (n = 10) of healthy controls and chronic HBV patients. We found distinct gene expression profiles between healthy controls and chronic HBV patients, as evidenced by 190 differentially expressed genes (DEG), but also between the clinical phenotypes of a chronic HBV infection (17-110 DEG between each phase). Numerous immune pathways, including the B cell receptor pathway were upregulated in liver B cells when compared to peripheral B cells. Further investigation of the detected DEG suggested an activation of B cells during HBeAg seroconversion and an active regulation of B cell signalling in the liver.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Activation; B cells; HBeAg seroconversion; Hepatitis B; Intrahepatic; RNA sequencing

Year:  2021        PMID: 33548734     DOI: 10.1016/j.cellimm.2021.104283

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  Editorial: The B-Side of B Cells.

Authors:  Alaitz Aranburu; Alessandro Camponeschi; Sven Geissler; Marcella Visentini; M Manuela Rosado
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

Review 2.  Clinical management of chronic hepatitis B: A concise overview.

Authors:  Arno Furquim d'Almeida; Erwin Ho; Stijn Van Hees; Thomas Vanwolleghem
Journal:  United European Gastroenterol J       Date:  2021-11-30       Impact factor: 4.623

Review 3.  Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV.

Authors:  Thomas Vanwolleghem; Tom Adomati; Stijn Van Hees; Harry L A Janssen
Journal:  JHEP Rep       Date:  2021-11-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.